Correction: Bähr et al. Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis. Biomolecules 2024, 14, 1236
Biomolecules · 10.07.2026 · 16 (7) · 1005
DOI: 10.3390/biom16071005 ↗Kurz gefasst
Korrektur in der Zeitschrift Biomolecules, online erschienen am 10.07.2026. Verfasst von Stella Bähr und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Engineering Sciences, Heidelberg University, 69120 Heidelberg, Germany. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health National Heart, Lung, And Blood Institute.
Abstract (Originalsprache)
In the original publication [...]
Autor:innen und Institutionen
- Faculty of Engineering Sciences, Heidelberg University, 69120 Heidelberg, Germany.
- Biosputnik LLC., New York, NY 10002, USA.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Emeritus Professor of Organic Chemistry and Biochemistry, University Hamburg, 20148 Hamburg, Germany.
ORCID-Profile: Stella Bähr, Ryan W Rue, Carly J Smith, Vera P Krymskaya
Förderung
- National Institutes of Health National Heart, Lung, And Blood Institute
Zitieren
APA
Bähr, S., Rue, R. W., Smith, C. J., Evans, J. F., Köster, H., Krymskaya, V. P., & Pleimes, D. (2026). Correction: Bähr et al. Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis. Biomolecules 2024, 14, 1236. Biomolecules, 16(7), 1005. https://doi.org/10.3390/biom16071005
Vancouver
Bähr S, Rue RW, Smith CJ, Evans JF, Köster H, Krymskaya VP, et al. Correction: Bähr et al. Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis. Biomolecules 2024, 14, 1236. Biomolecules. 2026;16(7):1005. doi:10.3390/biom16071005
BibTeX
@article{Bhr2026,
author = {Bähr, Stella and Rue, Ryan W and Smith, Carly J and Evans, Jillian F and Köster, Hubert and Krymskaya, Vera P and Pleimes, Dirk},
title = {Correction: Bähr et al. Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis. Biomolecules 2024, 14, 1236},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {7},
pages = {1005},
doi = {10.3390/biom16071005}
}
EUVIMED